search
Back to results

A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values

Primary Purpose

Prostate Cancer

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
MRI guided prostate biopsy and TRUS guided biopsy
Sponsored by
Heinrich-Heine University, Duesseldorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Prostate Cancer focused on measuring prostate biopsy, MRI guided biopsy, TRUS guided biopsy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • PSA > 4.0 ng/ml
  • written informed consent
  • age >18

Exclusion Criteria:

  • patients with prostate cancer
  • patients with prior prostate biopsy
  • patients with contraindications against MRI or biopsy

Sites / Locations

  • Department of Urology

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Sequentially MRI guided and TRUS guided biopsy

Arm Description

Targeted MRI guided biopsy according to findings in a multiparametric MRI followed by transrectal guided biopsy

Outcomes

Primary Outcome Measures

Prostate cancer detection rate

Secondary Outcome Measures

Number of Participants with Adverse Events as a measure of Safety and Tolerability

Full Information

First Posted
March 1, 2012
Last Updated
August 18, 2014
Sponsor
Heinrich-Heine University, Duesseldorf
search

1. Study Identification

Unique Protocol Identification Number
NCT01553838
Brief Title
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
Official Title
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values
Study Type
Interventional

2. Study Status

Record Verification Date
March 2012
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
October 2013 (Actual)
Study Completion Date
October 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Heinrich-Heine University, Duesseldorf

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether MRI guided prostate biopsy achieves higher prostate cancer detection rates compared with transrectal ultrasound guided prostate biopsy in patients with increased PSA values > 4.0 ng/ml.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prostate Cancer
Keywords
prostate biopsy, MRI guided biopsy, TRUS guided biopsy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Enrollment
185 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sequentially MRI guided and TRUS guided biopsy
Arm Type
Experimental
Arm Description
Targeted MRI guided biopsy according to findings in a multiparametric MRI followed by transrectal guided biopsy
Intervention Type
Device
Intervention Name(s)
MRI guided prostate biopsy and TRUS guided biopsy
Intervention Description
MRI guided prostate biopsy
Primary Outcome Measure Information:
Title
Prostate cancer detection rate
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Number of Participants with Adverse Events as a measure of Safety and Tolerability
Time Frame
3 years

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: PSA > 4.0 ng/ml written informed consent age >18 Exclusion Criteria: patients with prostate cancer patients with prior prostate biopsy patients with contraindications against MRI or biopsy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Arsov, MD
Organizational Affiliation
Department of Urology, University of Duesseldorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Urology
City
Duesseldorf
ZIP/Postal Code
40225
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values

We'll reach out to this number within 24 hrs